{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:45:27Z","timestamp":1760057127531,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ajem.2008.01.017","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T05:22:32Z","timestamp":1238131352000},"page":"348-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does timing matter? Upstream or downstream administration of antiplatelet therapy"],"prefix":"10.1016","volume":"27","author":[{"given":"David","family":"Slattery","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Charles V.","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2008.01.017_bib1","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.166.18.2027","article-title":"Recent trends in the care of patients with non\u2013ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative","volume":"166","author":"Mehta","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.CIR.101.5.570","article-title":"Recognition of the importance of embolization in atherosclerotic vascular disease","volume":"101","author":"Topol","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2008.01.017_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1197\/j.aem.2004.01.001","article-title":"Derivation and validation of a risk stratification model to identify coronary artery disease in women who present to the emergency department with potential acute coronary syndromes","volume":"11","author":"Diercks","year":"2004","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib5","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"Br Med J"},{"key":"10.1016\/j.ajem.2008.01.017_bib6","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2008.01.017_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mem.2002.129506","article-title":"The Erlanger Chest Pain Evaluation Protocol: a one-year experience with serial 12-lead ECG monitoring, two-hour delta serum marker measurements, and selective nuclear stress testing to identify and exclude acute coronary syndromes","volume":"40","author":"Fesmire","year":"2002","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11239-007-0013-0","article-title":"Modified Thrombolysis in Myocardial Infarction (TIMI) risk score to risk stratify patients in the emergency department with possible acute coronary syndrome","volume":"24","author":"Jaffery","year":"2007","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ajem.2008.01.017_bib9","first-page":"13","article-title":"Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population","volume":"13","author":"Pollack","year":"2006","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jacc.2005.04.037","article-title":"New risk score for patients with acute chest pain, non\u2013ST-segment deviation, and normal troponin concentrations: a comparison with the TIMI risk score","volume":"46","author":"Sanchis","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2008.01.017_bib12","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJM199610313351801","article-title":"Cardiac troponin T levels for risk stratification in acute myocardial ischemia","volume":"335","author":"Ohman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.annemergmed.2006.07.005","article-title":"Clinical policy: critical issues in the evaluation and management of adult patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"48","author":"Fesmire","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.281.8.707","article-title":"Prognostic value of the admission electrocardiogram in acute coronary syndromes","volume":"281","author":"Savonitto","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2008.01.017_bib16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib17","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjcard.2004.11.003","article-title":"Bivalirudin versus heparin and glycoprotein IIb\/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial)","volume":"95","author":"Chew","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib19","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.0000103623.63687.21","article-title":"Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction","volume":"108","author":"Sadeghi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2008.01.017_bib20","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0195-668X(03)00485-8","article-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","volume":"24","author":"Moscucci","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajem.2008.01.017_bib21","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2008.01.017_bib22","doi-asserted-by":"crossref","first-page":"70.e71","DOI":"10.1016\/j.amjmed.2005.07.043","article-title":"Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction","volume":"119","author":"Mehta","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib23","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non\u2013ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2008.01.017_bib24","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2005.09.080","article-title":"Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial","volume":"4","author":"Kirtane","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"5) (suppl 1","key":"10.1016\/j.ajem.2008.01.017_bib25","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1197\/j.aem.2007.03.944","article-title":"Use of clinical pharmacists in the academic EDs is limited","volume":"14","author":"Szczesiul","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"5) (suppl 1","key":"10.1016\/j.ajem.2008.01.017_bib26","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1197\/j.aem.2007.03.1282","article-title":"Medical and nursing staff highly value clinical pharmacists in the ED","volume":"14","author":"Hillebrand","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"5)(suppl 1","key":"10.1016\/j.ajem.2008.01.017_bib27","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1197\/j.aem.2007.03.1281","article-title":"Drug related problems (DRPs) in the emergency department (ED): clinical pharmacists improve detection of medication non-adherence","volume":"14","author":"Rudis","year":"2007","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2008.01.017_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel","volume":"350","author":"Kastrati","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib30","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2008.01.017_bib31","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndrome","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib32","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non\u2013ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"SYNERGY Trial Investigators","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2008.01.017_bib33","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1053\/euhj.2002.3385","article-title":"Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"23","author":"Bertrand","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajem.2008.01.017_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1197\/j.aem.2004.11.029","article-title":"Early glycoprotein IIb\/IIIa inhibitor use for non\u2013ST-segment elevation acute coronary syndrome: patient selection and associated treatment patterns","volume":"12","author":"Hoekstra","year":"2005","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib35","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.100.20.2045","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibition in non\u2013ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention","volume":"100","author":"Boersma","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2008.01.017_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0735-1097(03)00514-X","article-title":"Early use of glycoprotein IIb\/IIIa inhibitors in non\u2013ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4","volume":"42","author":"Peterson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing Trial","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2008.01.017_bib38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ahj.2005.03.029","volume":"149","author":"Giugliano","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ajem.2008.01.017_bib39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2008.01.017_bib40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ajem.2008.01.017_bib41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajem.2008.01.017_bib42","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non\u2013ST-segment elevation acute coronary syndromes","volume":"28","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajem.2008.01.017_bib43","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjcard.2006.03.040","article-title":"Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"98","author":"Mehta","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jacc.2004.03.081","article-title":"A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non\u2013ST-segment elevation myocardial infarction","volume":"44","author":"Sadanandan","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ajem.2008.01.017_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1067\/mem.2003.88","article-title":"2002 update to the ACC\/AHA guidelines for the management of patients with unstable angina and non\u2013ST-segment elevation myocardial infarction: implications for emergency department practice","volume":"41","author":"Pollack","year":"2003","journal-title":"Ann Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675708000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675708000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:11:04Z","timestamp":1760022664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675708000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0735675708000867"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2008.01.017","relation":{},"ISSN":["0735-6757"],"issn-type":[{"type":"print","value":"0735-6757"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does timing matter? Upstream or downstream administration of antiplatelet therapy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2008.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}